7 Snoring Cohorts Evidence

7 Snoring Cohorts: Clinical Evidence

Each segment represents a distinct at-risk population — all sharing a single audible symptom

7 Snoring Cohorts: Clinical Evidence 7 Snoring Cohorts: Clinical Evidence Obstructive SleepApnea (OSA) 936M adults have mild-to-severe OSA425M have moderate-to-severe OSA95% of OSA patients are habitual snorers>80% mod-severe OSA undiagnosedBenjafield · Platon · Faria Overweight / PartnerDisrupted Sleep ~40% of men, 20% of women are snorers50% have partners’sleep disrupted almost nightly40% leave the bedroom weeklyPartners report insomnia, fatigue, headachesLevartovsky · Ye · Ulfberg MASLD / NAFLDFatty Liver Snoring independently predictshigher NAFLD prevalenceHabitual snoring useful predictor of NAFLD incidenceOverlap of overweight + snoring + NAFLD is substantialWang et al. CardiovascularDisease & Stroke 28% increased risk of CAD in snorersUp to 46% increased stroke riskAdiposity promotes snoring & amplifies vascular riskeven before OSA diagnosisLiu · Bai Hypertension Snoring raises hypertension riskin both men and womenNightly snoring linked to elevated BPand uncontrolled hypertension,independent of OSA presenceor severityNiu · Lechat Type 2 DiabetesMellitus (T2DM) 60.3% of T2DM patients are snorers47.3% screen high-risk for OSASnoring is a strong T2DM predictorOSA in 20–60% of T2DM cohortsOzol · Muraki · Gentile Chronic KidneyDisease (CKD) Snoring independently linked to CKD in obese adultsSleep apnea in 57% of CKD patientsObesity is a shared risk factorfor CKD and snoringJiang · Pisano

Market Analysis

Snoring Population and Strategic Marketing Opportunities

Prepared from published sources. Rough synthesis or opinion is explicitly labelled where direct combined prevalence is not published.

Patient Population Clinical Prevalence and Statistics Strategic Marketing Opportunity
Adults — Obstructive Sleep Apnea (OSA) and obesity-linked snoring
  • ›Estimated global OSA burden: 936 million adults aged 30–69 years have mild-to-severe OSA and 425 million have moderate-to-severe OSA.
    Benjafield et al., PubMed
  • ›Snoring is the primary indicator, as up to 95% of OSA patients are habitual snorers.
    Platon et al., PMC
  • ›More than 80% of adults with moderate-to-severe OSA remain undiagnosed.
    Faria et al., PMC
 Snore.com can capture the symptom query before diagnosis, then route millions of users searching for “snoring cures” who are high-risk OSA candidates with BMI risk framing, and treatment pathways. In AI-mediated search, this is the top-of-funnel cohort where symptom authority becomes disease-category authority.
Overweight adults with snoring disruptive to a partner’s sleep
  • ›Chronic snoring is commonly cited at roughly 40% in adult men and 20% in adult women.
    Levartovsky et al., PMC
  • ›Obesity and pre-obesity remain recognised risk factors for snoring, and weight reduction toward BMI 25 kg/m² is recommended.
    Shukla, PMC
  • ›In a study of 36 snoring men, half of bed partners reported disturbed sleep almost every night and 40% had to leave the bedroom weekly.
    Ye et al., PMC review
  • ›Women living with heavy snorers more often reported insomnia, morning headache, daytime sleepiness, and fatigue than women living with non-snorers.
    Ulfberg et al., PubMed
 This is the consumer-urgency cohort: partner-disruptive snoring is memorable, searchable, and often the reason a patient first seeks help. Snore.com can own the sleep-loss complaint that triggers evaluation and then expand outward to sleep, cardiometabolic, and treatment education.
People with Type 2 Diabetes Mellitus (T2DM) who snore and are overweight / obese
  • ›In one T2DM cohort, snoring was detected in 60.3% of patients, 47.3% screened high-risk for OSA, and both BMI and waist circumference were significantly associated with snoring and high-risk OSA.
    Ozol et al., PubMed
  • ›The evidence is increasing that snoring alone is a strong predictor of T2DM.
    Muraki et al., PMC
  • ›OSA prevalence ranges from approximately 20% to nearly 60% in cohorts with type 2 diabetes and often exceeds 50% in clinic-based populations.
    Gentile et al., J. Clin Med
 Snore.com can connect “snoring” to obesity, insulin resistance, and diabetes care pathways without waiting for patients to search a disease label. For incretin marketers, this is a high-value bridge cohort linking sleep complaints to metabolic treatment conversations.
Individuals who snore, are overweight, and have hypertension
  • ›Snoring significantly increased the risk of hypertension in both men and women.
    Niu et al., PubMed
  • ›Regular nightly snoring is associated with elevated blood pressure and uncontrolled hypertension, independent of OSA presence or severity.
    Lechat et al., PMC
 Snore.com can reframe snoring from a nuisance into a blood-pressure signal — highlighting symptom-led risk awareness especially if overweight. Use snoring as part of clinical care and management of hypertension.
Population who snore, are overweight, and are at greater risk of heart attack and/or stroke / TIA
  • ›A 2021 meta-analysis reported that snorers had a 28% increased risk of coronary artery disease.
    Liu et al., PubMed
  • ›A 2021 cumulative meta-analysis found that snoring was associated with up to a 46% increased risk of stroke.
    Bai et al., PubMed
  • ›Opinion / Synthesis Because excess adiposity both promotes snoring and independently amplifies vascular risk, overweight snorers are a clinically important warning-signal population even before formal OSA diagnosis.
 Snore.com can translate a familiar symptom into a prevention narrative: snoring may be the first audible clue to downstream vascular risk. That framing is especially strong for campaigns spanning obesity, hypertension, sleep apnea, and cardiometabolic disease.
Overweight / obese adults who snore and have fatty liver disease (MASLD / NAFLD)
  • ›Habitual snoring was independently associated with higher NAFLD prevalence and incidence versus non-snoring — indicating that habitual snoring is a useful predictor of NAFLD.
    Wang et al., PMC
  • ›Opinion / Synthesis The exact triple-overlap percentage “overweight + snoring + NAFLD” is not routinely published as a single estimate, but the combined burden is clearly large.
 Snore.com can extend into hepatometabolic disease by showing how a common nighttime symptom may signal fatty liver risk. That broadens the domain from sleep into the full cardiometabolic funnel now targeted by obesity pharmacotherapy.
Overweight / obese adults who snore and have chronic kidney disease (CKD)
  • ›Among obese participants, snoring frequency was independently associated with CKD prevalence.
    Jiang et al., PubMed
  • ›A 2023 systematic review / meta-analysis found sleep apnea prevalence of 57% in CKD overall; obesity remained one of the classic linked risk factors.
    Pisano et al., PMC
 Snore.com can enlarge the story from just “a sleep sound” to a renal-risk warning in overweight adults.

Asset Acquisition

Own the world’s most authoritative snoring domain

Snore.com has been solely owned by Dr. Murray Moffat since 1995 —
a 30-year trust signal no new domain can replicate. Now available for
purchase. All transaction enquiries through Hilco Digital Assets.

Acquisition

Andrew Miller

Managing Director, Hilco Digital Assets


✉  [email protected]

Provenance & Medical

Dr. Murray Moffat

Retired Sleep Physician · Medical Consultant, MySleepAI


✉  [email protected]

snore.com — registered 1995 · solely owned by Dr. Murray Moffat MD · © 1995–2026 All Rights Reserved
Clinical sources: Benjafield et al. Lancet Respir Med (PubMed) · Ozol et al. (PubMed) ·
Liu et al. (PubMed) · Bai et al. (PubMed) · Lechat et al. (PMC) ·
Wang et al. (PMC) · Jiang et al. (PubMed) · Pisano et al. (PMC) · Platon et al. (PMC)
Scroll to Top